A retrospective study suggests that low dose Abilify is safe and may be helpful in reducing fatigue and post-exertional malaise and improving cognition and sleep in chronic fatigue syndrome. A placebo-controlled study is needed to determine how effective low dose Abilify is.
How a person with chronic fatigue syndrome (ME/CFS) improved their health and quality of life by pacing using heart rate and heart rate variability monitoring
Jarred Younger – the creator of the Neuroinflammation, Pain and Fatigue Laboratory – is committed. He knows neuroinflammation plays a role in fibromyalgia (FM) and chronic fatigue syndrome (ME/CFS) and his lab is dedicated to showing that. So far –...
The Long COVID Funding The 2020 COVID-19 Economic Relief bill had been months and months in the making, and while Emily Taylor, the lead advocate for the Solve ME/CFS Initiative (Solve M.E.), had publicly shared nothing, she was keeping a very close eye on the long...
Long COVID researchers are finding evidence of autonomic nervous dysfunction, small fiber neuropathy, brainstem damage and angiotensin problems. All these are also found in chronic fatigue syndrome
A study suggested that changes to factors which influence gene expression in chronic fatigue syndrome have dysregulated the immune system leading to increased inflammation during exercise.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.